Brazil reviews malaria facilities, invests in equipment
This article was originally published in Clinica
Executive Summary
Brazilian healthcare authorities are investing in malaria diagnostics equipment, following a review of the facilities developed under the national malaria control programme (PNCM), launched in 2003. The scale of the programme is impressive: there are 2,860 malaria diagnostics laboratories in 805 municipalities, supported by over 14,000 notification units and almost 37,000 staff (excluding doctors and other clinical care staff). The programme has so far resulted in a significant fall in incidence rate, from 31.9 per 1,000 inhabitants in 1999, to 18.3 per 1,000 in 2003, and a fall in case fatality rate, from 0.30 to 0.23 per 1,000 cases, over the same period.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.